Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV
This cross-sectional study examines the use of long-acting injectable antiretroviral therapy among Medicare beneficiaries with HIV and characterizes the differences between people receiving oral antiretroviral therapy vs long-acting injectable antiretroviral therapy.
Authors
- Jessica Phelan (ORCID: https://orcid.org/0000-0001-7008-7744)
- Shibani S. Mukerji (ORCID: https://orcid.org/0000-0002-5677-6954)
- Grace Luu
- Jose F. Figueroa
- E John Orav (ORCID: https://orcid.org/0000-0002-8886-7252)
- EMILY P. HYLE
- Rebekah I. Stein
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-06-12
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.18029
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00